文献
J-GLOBAL ID:202202218106042619
整理番号:22A0448941
MR誘導下のリンパ節転移の定位放射線治療:最初の臨床結果と患者報告転帰【JST・京大機械翻訳】
Stereotactic body radiotherapy of lymph node metastases under MR-guidance: First clinical results and patient-reported outcomes
著者 (42件):
Weykamp Fabian
(Department of Radiation Oncology, Heidelberg University Hospital, Heidelberg, Germany)
,
Weykamp Fabian
(Heidelberg Institute of Radiation Oncology (HIRO), Heidelberg University Hospital, Heidelberg, Germany)
,
Weykamp Fabian
(National Center for Tumor diseases (NCT), Heidelberg University Hospital, Heidelberg, Germany)
,
Herder-Wagner Charlotte
(Department of Radiation Oncology, Heidelberg University Hospital, Heidelberg, Germany)
,
Regnery Sebastian
(Department of Radiation Oncology, Heidelberg University Hospital, Heidelberg, Germany)
,
Regnery Sebastian
(Heidelberg Institute of Radiation Oncology (HIRO), Heidelberg University Hospital, Heidelberg, Germany)
,
Regnery Sebastian
(National Center for Tumor diseases (NCT), Heidelberg University Hospital, Heidelberg, Germany)
,
Hoegen Philipp
(Department of Radiation Oncology, Heidelberg University Hospital, Heidelberg, Germany)
,
Hoegen Philipp
(Heidelberg Institute of Radiation Oncology (HIRO), Heidelberg University Hospital, Heidelberg, Germany)
,
Hoegen Philipp
(National Center for Tumor diseases (NCT), Heidelberg University Hospital, Heidelberg, Germany)
,
Hoegen Philipp
(Clinical Cooperation Unit Radiation Oncology, German Cancer Research Center (DKFZ), Heidelberg, Germany)
,
Renkamp C. Katharina
(Department of Radiation Oncology, Heidelberg University Hospital, Heidelberg, Germany)
,
Renkamp C. Katharina
(Heidelberg Institute of Radiation Oncology (HIRO), Heidelberg University Hospital, Heidelberg, Germany)
,
Renkamp C. Katharina
(National Center for Tumor diseases (NCT), Heidelberg University Hospital, Heidelberg, Germany)
,
Liermann Jakob
(Department of Radiation Oncology, Heidelberg University Hospital, Heidelberg, Germany)
,
Liermann Jakob
(Heidelberg Institute of Radiation Oncology (HIRO), Heidelberg University Hospital, Heidelberg, Germany)
,
Liermann Jakob
(National Center for Tumor diseases (NCT), Heidelberg University Hospital, Heidelberg, Germany)
,
Rippke Carolin
(Department of Radiation Oncology, Heidelberg University Hospital, Heidelberg, Germany)
,
Rippke Carolin
(Heidelberg Institute of Radiation Oncology (HIRO), Heidelberg University Hospital, Heidelberg, Germany)
,
Rippke Carolin
(National Center for Tumor diseases (NCT), Heidelberg University Hospital, Heidelberg, Germany)
,
Koerber Stefan A.
(Department of Radiation Oncology, Heidelberg University Hospital, Heidelberg, Germany)
,
Koerber Stefan A.
(Heidelberg Institute of Radiation Oncology (HIRO), Heidelberg University Hospital, Heidelberg, Germany)
,
Koerber Stefan A.
(National Center for Tumor diseases (NCT), Heidelberg University Hospital, Heidelberg, Germany)
,
Konig Laila
(Department of Radiation Oncology, Heidelberg University Hospital, Heidelberg, Germany)
,
Konig Laila
(Heidelberg Institute of Radiation Oncology (HIRO), Heidelberg University Hospital, Heidelberg, Germany)
,
Konig Laila
(National Center for Tumor diseases (NCT), Heidelberg University Hospital, Heidelberg, Germany)
,
Buchele Carolin
(Department of Radiation Oncology, Heidelberg University Hospital, Heidelberg, Germany)
,
Buchele Carolin
(Heidelberg Institute of Radiation Oncology (HIRO), Heidelberg University Hospital, Heidelberg, Germany)
,
Buchele Carolin
(National Center for Tumor diseases (NCT), Heidelberg University Hospital, Heidelberg, Germany)
,
Klueter Sebastian
(Department of Radiation Oncology, Heidelberg University Hospital, Heidelberg, Germany)
,
Klueter Sebastian
(Heidelberg Institute of Radiation Oncology (HIRO), Heidelberg University Hospital, Heidelberg, Germany)
,
Klueter Sebastian
(National Center for Tumor diseases (NCT), Heidelberg University Hospital, Heidelberg, Germany)
,
Debus Juergen
(Department of Radiation Oncology, Heidelberg University Hospital, Heidelberg, Germany)
,
Debus Juergen
(Heidelberg Institute of Radiation Oncology (HIRO), Heidelberg University Hospital, Heidelberg, Germany)
,
Debus Juergen
(National Center for Tumor diseases (NCT), Heidelberg University Hospital, Heidelberg, Germany)
,
Debus Juergen
(Heidelberg Ion-Beam Therapy Center (HIT), Department of Radiation Oncology, Heidelberg University Hospital, Heidelberg, Germany)
,
Debus Juergen
(Clinical Cooperation Unit Radiation Oncology, German Cancer Research Center (DKFZ), Heidelberg, Germany)
,
Debus Juergen
(core center Heidelberg, German Cancer Consortium (DKTK), Heidelberg, Germany)
,
Horner-Rieber Juliane
(Department of Radiation Oncology, Heidelberg University Hospital, Heidelberg, Germany)
,
Horner-Rieber Juliane
(Heidelberg Institute of Radiation Oncology (HIRO), Heidelberg University Hospital, Heidelberg, Germany)
,
Horner-Rieber Juliane
(National Center for Tumor diseases (NCT), Heidelberg University Hospital, Heidelberg, Germany)
,
Horner-Rieber Juliane
(Clinical Cooperation Unit Radiation Oncology, German Cancer Research Center (DKFZ), Heidelberg, Germany)
資料名:
Strahlentherapie und Onkologie
(Strahlentherapie und Onkologie)
巻:
198
号:
1
ページ:
56-65
発行年:
2022年
JST資料番号:
D0259B
ISSN:
0179-7158
資料種別:
逐次刊行物 (A)
記事区分:
原著論文
発行国:
ドイツ (DEU)
言語:
英語 (EN)